InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Dorenbaum Alejandro, Directeur Médical. Director active across 1 company, notably Reneo Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been recorded. History available since 10 December 2021. The latest transaction was filed on 12 August 2022 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Alejandro Dorenbaum is the Chief Medical Officer at Reneo Pharmaceuticals, Inc. He is responsible for leading the company's medical and clinical initiatives. With strong experience in the pharmaceutical sector, he plays a key role in developing new treatments and in Reneo's strategic direction.